[ RECIPIENT ENTITY RECORD ]

Prometheus Biosciences

VERIFIED NODE ID: 001718 · prometheus-biosciences
R TARGET NODE — CAPITAL RECIPIENT
Prometheus Biosciences
Company United States
Recipient Type
Company
Primary Jurisdiction
United States
Registration Status
ACTIVE
Entity Intelligence [ R ]
Legal Name Prometheus Biosciences
Entity Type Company
Jurisdiction United States
Recipient Intelligence Summary

Prometheus Biosciences is a biotechnology firm that utilizes a proprietary precision medicine platform to discover and develop therapeutic and diagnostic products. Based in California, the company focuses on the treatment of immune-mediated diseases. It was a major destination for institutional healthcare capital through its strategic acquisition.

Capital Influx Log (Transactions)
Date Type Amount
22 May 2026 EQUITY $10.8B